Therapeutic Advances in Endocrinology and Metabolism

Papers
(The median citation count of Therapeutic Advances in Endocrinology and Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Controversies in the management of active Charcot neuroarthropathy98
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study63
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults51
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review31
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review21
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity21
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease20
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis20
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers20
Update on genetics and epigenetics in metabolic associated fatty liver disease18
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system17
Is there a causal relationship between hypothyroidism and hyponatremia?16
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor16
Pheochromocytoma: a changing perspective and current concepts16
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study15
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus15
Retraction notice15
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication14
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective14
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes13
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study13
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study13
Bone health in transgender people: a narrative review13
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis13
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes13
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis13
Thanks to Reviewers12
Gender-affirming endocrine care for youth with a nonbinary gender identity12
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c11
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis10
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review10
Timing of osteoporosis therapies following fracture: the current status9
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study9
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease9
Implications of gender-affirming endocrine care for sports participation8
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions8
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease8
Qualitative evaluation of the symptoms and quality of life impacts of long-chain fatty acid oxidation disorders8
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis7
Association of body mass index and sarcopenia with osteoporosis: a predictive nomogram model for risk assessment7
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome7
Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series7
Physical activity among adults with type 2 diabetes mellitus in Jordan: a qualitative study7
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes7
The association between diabetes mellitus and incidence of depressive episodes is different based on sex: insights from ELSA-Brasil7
Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study6
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study6
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol6
Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives6
Association of serum parathyroid hormone within normal range with the prevalence and prognosis among adults with diabetes and prediabetes: insight from NHANES 2003–2006 data6
Successful management of hypercalcemic crisis by continuous renal replacement therapy with regional citrate anticoagulation and surgery: a case report6
Association of hyponatremia with bone mineral density and fractures: a narrative review6
Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans5
COVID-19 and the hidden threat of diabetic microvascular complications5
RANKL inhibition: a new target of treating diabetes mellitus?5
Fractures and dislocations of the foot and ankle in people with diabetes: a literature review4
Fertility preservation options for transgender and nonbinary individuals4
HbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort4
Hyponatraemia in patients on immune checkpoint inhibitors4
Effects of 12-week combined interval running and resistance training on cardiac structure and performance in patients with type 1 diabetes4
Emerging pharmacological treatment options for MAFLD4
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis4
Menopause, androgens, and cardiovascular ageing: a narrative review4
Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study4
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study4
Incidence and predictors of hyperglycemic emergencies among adult diabetic patients at public hospitals of Sidama Region and Gedeo Zone, Southern Ethiopia: a survival analysis3
Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)3
Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone3
Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study3
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke3
ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients3
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us3
Real-world evidence of the use of glucocorticoids for severe COVID-193
0.046859979629517